News
The U.S. regulator has signed off on Corstasis Therapeutics’ Enbumyst to relieve the edema associated with congestive heart ...
More than 40 years after establishing the first U.S. pharmaceutical joint venture in China, Bristol Myers Squibb is handing ...
For aura enthusiasts, puppy fanatics and pharma marketing gurus alike, the inaugural Fierce Pharma Week looked pretty sweet.
This holiday season, Abbott is sure to warm hearts in a Hallmark Channel film that puts the company’s medical devices and its ...
After HHS secretary Robert F. Kennedy Jr. overhauled the CDC's vaccine advisory panel over the summer, he's adding to the group's lineup with five new members.
James Potter, the executive director at Coalition for Healthcare Communication (CHC), has rose-colored glasses on. | In a ...
The resulting report, published this week ahead of Swoop’s presentation at the Fierce Pharma Week conference in Philadelphia, ...
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug ...
As Robert F. Kennedy Jr.’s revamped Centers for Disease Control and Prevention (CDC) vaccine advisory panel gears up to meet ...
The detailed results from the HARMONi trial—the first global phase 3 data set for the world’s first PD-1xVEGF bispecific, ...
While Gilead Sciences previously ponied up hundreds of millions of dollars to resolve kickback allegations related to its HIV ...
Following CapVest Partners' takeover of Germany’s Stada earlier this month, another private equity group is looking to cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results